Tech Company Financing Transactions
Parse Biosciences Funding Round
Parse Biosciences, based in Seattle, received $7 million from Bioeconomy Capital and private investors.
Transaction Overview
Company Name
Announced On
1/27/2021
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Bioeconomy Capital (Lead Investor)
Proceeds Purpose
The new funding will be used to continue scaling the commercial roll-out of Parse Bioscience's Whole Transcriptome Kit, which enables researchers to profile up to 100,000 cells in parallel across up to 48 samples.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 Elliott Ave. W 209
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Undisclosed
Website
Email Address
Overview
Parse Biosciences is a company with the mission of accelerating progress in human health and scientific research. At the core of the company is a pioneering approach for single cell sequencing. Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Rosenberg
Chief Technical Officer
Charlie Roco
Browse more venture capital transactions:
Prev: 1/26/2021: Sounding Board venture capital transaction
Next: 1/27/2021: Span venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs